Garrett M. Frampton
Foundation Medicine (United States)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Genetic factors in colorectal cancer, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Histone H3K27ac separates active from poised enhancers and predicts developmental state(2010)4,450 cited
- → Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial(2016)3,687 cited
- → Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden(2017)3,671 cited
- → Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers(2017)2,359 cited
- → Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing(2013)2,153 cited
- → STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma(2018)1,562 cited
- → Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells(2008)1,361 cited
- → Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis(2011)982 cited
- → Co-occurring Genomic Alterations Define Major Subsets of KRAS -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities(2015)897 cited
- → Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies(2012)862 cited